Low-Dose Naltrexone
Category
other
Routes
Oral (PO)
Half-Life (t½)
PO: 4h
Formula
C25H23N6+
Molecular Weight
341.41 g/mol
PubChem CID
45382306
Aliases
ldn, naltrexone
Pharmacological Mechanism
Transient mu-opioid antagonism; upregulates endogenous endorphins.
Half-Life & Elimination Curve (PO: 4h)
100%
50%
25%
12.5%
0%
0h
0×t½
4h
1×t½
8h
2×t½
12h
3×t½
16h
4×t½
20h
5×t½
0×t½ (0h): 100% remaining
1×t½ (4h): 50% remaining
2×t½ (8h): 25% remaining
3×t½ (12h): 12.5% remaining
4×t½ (16h): 6.3% remaining
5×t½ (20h): 3.1% remaining
Elimination (PO)
0×t½
0h
100%
1×t½
4h
50%
2×t½
8h
25%
3×t½
12h
12.5%
4×t½
16h
6.3%
5×t½
20h
3.1%
Elimination t½
4h (PO)
Rate Constant (ke)
0.173 h⁻¹
97% Washout (5×t½)
20h
Dosing Guidelines
Oral (PO):
Typical 4.5 mg (Range: 0.5–4.5 mg)
Pathways It Modulates
Opioid receptor signaling
(inhibitor) — μ-opioid (low-dose, paradoxical microglial modulation)
Target Organ Systems
nervous
Chemical Structure & Identifiers
InChIKey:
CDOVNWNANFFLFJ-UHFFFAOYSA-O
SMILES:
C1CN(CCN1)C2=CC=C(C=C2)C3=CN=C4C(=CN[N+]4=C3)C5=CC=NC6=CC=CC=C56
References
PMID 24526585
Directory
Compounds Registry
Human Biology Hub
Teahann Knowledge Base
Human
Pharmacology
Chemistry
Physics
Astronomy
Botany
Engineering
Geography
Geology
Mesopotamia
Ancient Egypt
Classical Greece
Ancient Rome
Norse & Germanic
Vedic & Classical India
Ancient & Imperial China
Mesoamerica & Andes
Cybersecurity
Network Ports
Web APIs
Computing
Mathematics
Architecture
Philosophy
Psychology
Mythology
Harry Potter
Economics
History
Linguistics
Literature
Music
Sources & Licences